Dr. Christopher Benz is a clinical oncologist and a translational researcher with faculty appointments at the Buck Institute for Research on Aging, where as a founding faculty member he conducts laboratory breast cancer research, and at UCSF’s HDFCCC’s Breast Care Center and Breast Oncology Program, where he treats breast cancer patients and participates in major clinical research efforts like I-SPY2, serving as a founding member on its New Agent and Biomarker Committees. Along with bioinformatic scientists at UCSC and UCSF, Dr. Benz also co-directs one of the NCI’s Genome Data Analysis Centers, which recently completed it groundbreaking “PanCancer Atlas” project, molecularly characterizing over 10,000 human tumors across 33 different cancer types, producing a new re-classification of cancers that is expected to better inform clinical trials and drive more effective and personalized cancer therapy.